- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01640392
MyLife MyStyle Evaluation Project (MLMS)
August 13, 2019 updated by: Los Angeles County Department of Public Health
Evaluating Locally Developed Homegrown HIV Prevention Interventions
The purpose of the MyLife MyStyle Evaluation Project is to determine whether the MyLife MyStyle group-level intervention reduces HIV sexual-risk behaviors among 18- to 29-year-old African American men who have sex with men (MSM).
Specifically, the project will test whether participants of the MyLife MyStyle program will report at least a 15% absolute decrease in frequency of unprotected anal sex with male partners at three and six months post-intervention compared with the wait-list control participants.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In Los Angeles County, as well as nationally, the primary mode of HIV transmission for African American men is sexual contact with another man.
According to national data from 45 states with name-based HIV surveillance in 2006, the majority of all new HIV infections among African American males were associated with sex with other men.
The disproportionate impact of HIV in AAMSM in Los Angeles County is also observed in provisional HIV surveillance data.
Between 2002 and 2004, AAMSM composed 16.3% of the new HIV diagnoses among males in Los Angeles County, with an average annual HIV diagnosis rate 2.0 and 2.5 times greater than the rates of new HIV diagnosis for White and Latino MSM, respectively.
In addition to demonstrating the highest HIV prevalence and incidence estimates, AAMSM also had the highest proportion of previously unrecognized HIV infection (67%) compared with all other racial/ethnic groups.
Given significant and continuing disparities in HIV infection among African Americans in the United States, and specifically among AAMSM, more intervention programs must be planned, implemented, and tested in order to reduce the heavy toll of HIV/AIDS in this population.
Components of these intervention programs must be culturally competent and should include promotion of HIV counseling and testing to reduce the high prevalence of unrecognized HIV infection in AAMSM.
Interventions should also take into consideration the many co-factors that may hinder AAMSM from addressing their HIV risk such as racism, poverty, stigma, and homophobia.
The MyLife MyStyle Evaluation Project aims to implement and evaluate the efficacy of a "homegrown" group-level intervention to reduce HIV risk (unprotected anal sex with male partners) among young African American MSM in Los Angeles County, CA.
Study Type
Interventional
Enrollment (Actual)
528
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90019
- In The Meantime Men's Group, Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 29 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Identify as African American or Black
- Identify as male
- Age 18 to 29 years
- Reside within Los Angeles County
- Self-reported anal sex with a male partner in the past 12 months
- Has not participated in an HIV prevention intervention in the past 3 months
- Able to complete ACASI and MyLife sessions in English
Exclusion Criteria:
- Identify as a transgender female
- Plan to move out of Los Angeles County before the end of their follow-up period (within 7 months)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: HIV prevention groups
Participants randomly assigned to the MyLife Intervention arm receive three 1.5-hour HIV behavioral risk-reduction group sessions over a 1-3 week period.
|
Three 1.5-hour HIV behavioral risk-reduction group sessions conducted with up to 12 young African American/Black men (ages 18-29 years) over a 1-3 week period.
|
|
NO_INTERVENTION: Wait-list control
Participants randomly assigned to the Wait-list Control arm receive the MyLife MyStyle group sessions once they have completed a 6-month follow-up assessment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduced unprotected anal sex with male partners
Time Frame: up to 6 months following Intervention groups' third (final) session
|
Proportion of intervention participants reporting any unprotected anal intercourse (either insertive or receptive) with male partners at six-month follow-up (and three months for short-term effects) compared with those in the wait-list control arm.
|
up to 6 months following Intervention groups' third (final) session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Increased communication with partners
Time Frame: 3 months and 6 months following intervention groups' third (final) session
|
Increase frequency of communication with partner(s) about safer sex, HIV status, STI status
|
3 months and 6 months following intervention groups' third (final) session
|
|
Decrease unprotected sex because condom was not available
Time Frame: 3 months and 6 months following Intervention groups' third (final) session
|
Proportion of intervention participants reporting episodes of unprotected anal sex when a condom is not available at six-month follow-up (and three months for short-term effects) compared with those in the wait-list control arm.
|
3 months and 6 months following Intervention groups' third (final) session
|
|
Decrease number of sexual partners
Time Frame: 3 months and 6 months following Intervention groups' third (final) session
|
Number of sexual partners reported by intervention participants at six-month follow-up (and three months for short-term effects) compared with the number reported by the wait-list control participants.
|
3 months and 6 months following Intervention groups' third (final) session
|
|
Increase help-seeking behaviors for sexual health, e.g., STI testing, HIV testing, health screenings
Time Frame: 3 months and 6 months following Intervention groups' third (final) session
|
Proportion of intervention participants reporting help-seeking behaviors for sexual health at six-month follow-up (and three months for short-term effects) compared with those in the wait-list control arm.
|
3 months and 6 months following Intervention groups' third (final) session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Trista Bingham, MPH, PhD, Los Angeles County Department of Public Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (ACTUAL)
April 1, 2015
Study Completion (ACTUAL)
April 1, 2015
Study Registration Dates
First Submitted
July 11, 2012
First Submitted That Met QC Criteria
July 12, 2012
First Posted (ESTIMATE)
July 13, 2012
Study Record Updates
Last Update Posted (ACTUAL)
August 15, 2019
Last Update Submitted That Met QC Criteria
August 13, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1 U01SP001573-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Unsafe Sex
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteCompletedUnsafe Sex | Unprotected SexUnited States
-
Rong ZhangRecruiting
-
The University of Hong KongCompletedAdolescent Behavior | Behavior, Sex | Sex, UnsafeHong Kong
-
North Carolina Agriculture & Technical State UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Not yet recruitingSexual Assault | Condomless SexUnited States
-
Phoenix Children's HospitalCompletedIV Drug Usage | Unsafe SexUnited States
-
Boston University Charles River CampusNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol; Harmful Use | Sex, UnsafeUnited States
-
Nova Southeastern UniversityJohn H. Stroger HospitalCompletedRisk Reduction | Unsafe SexUnited States
-
San Francisco State UniversityNational Institute of Mental Health (NIMH); Drexel University; Chicago Queer...RecruitingHelp-Seeking Behavior | Condomless Sex | Risky Health Behavior | Pre-exposure Prophylaxis UseUnited States
-
University of Southern CaliforniaUniversity of California, San DiegoCompletedDepression | HIV/AIDS | Methamphetamine Abuse | Sex, UnsafeUnited States
-
Brown UniversityNational Institute of Mental Health (NIMH)CompletedSexual Assault | Unsafe Sex | Physical Violence | Sexual AbuseUnited States
Clinical Trials on MyLife MyStyle group-level intervention
-
Emory UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Universidade Norte do ParanáNot yet recruitingEffects of Photobiomodulation on the Innate Immune System of Neonates and Infants With BronchiolitisBronchiolitis | Virus Disease | VirusBrazil
-
Ting Chang, MDHebei Senlang Biotechnology Co., LTDActive, not recruitingMyasthenia Gravis, GeneralizedChina
-
Newcastle UniversityUniversity of Oslo; University College Dublin; Technical University of Munich; Maastricht... and other collaboratorsCompletedDietary ModificationNetherlands, Germany, Greece, Ireland, Poland, Spain, United Kingdom
-
Georgetown UniversityUniversity of Colorado, Denver; NYU Langone Health; Seattle Children's Hospital; University of North Carolina, Chapel Hill and other collaboratorsActive, not recruitingChildhood Cancer | Adherence, Patient | Health Knowledge, Attitudes, Practice | Health Care Utilization | SurvivorshipUnited States
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingType 2 Myocardial InfarctionUnited States
-
University of Alabama at BirminghamCompletedSickle Cell DiseaseUnited States
-
VA Office of Research and DevelopmentCompleted
-
University of Eastern FinlandVTT Technical Research Centre of Finland; City of Kuopio; Savonia University... and other collaboratorsCompleted
-
University of Alabama at BirminghamCompletedViolence in AdolescenceUnited States